# OnCo record paper-sandler-ecog-4599-bevacizumab-nsclc-nejm-2006 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-sandler-ecog-4599-bevacizumab-nsclc-nejm-2006/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-sandler-ecog-4599-bevacizumab-nsclc-nejm-2006" ;
  schema:name "Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer"@en ;
  schema:description "Adding an antibody against the tumour's blood supply to chemotherapy pushed median survival past a year for the first time in advanced lung cancer, at the cost of more treatment-related deaths."@en ;
  schema:url <https://onco.cc/key-papers/paper-sandler-ecog-4599-bevacizumab-nsclc-nejm-2006/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa061884>, <https://pubmed.ncbi.nlm.nih.gov/17167137/>, <https://clinicaltrials.gov/study/NCT00021060> ;
  onco:tag "lung-evidence" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa061884> ;
  schema:datePublished "2006"^^xsd:gYear ;
  schema:author "Sandler A, Gray R, Perry MC, et al." ;
  onco:related <https://onco.cc/key-papers/paper-scagliotti-cisplatin-pemetrexed-histology-jco-2008/>, <https://onco.cc/roadmaps/targeted-therapy-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/lung-adenocarcinoma/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:companies <https://onco.cc/companies/ecog-acrin/> ;
  onco:pathways <https://onco.cc/terms/angiogenesis/> ;
  onco:terms <https://onco.cc/terms/brain-metastases/>, <https://onco.cc/terms/performance-status/>, <https://onco.cc/terms/histology/> ;
  onco:people <https://onco.cc/people/julie-brahmer/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-biomarker-validation/>, <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-trial-enrolment/> ;
  onco:journals <https://onco.cc/journals/nejm/> .